1-(p-tolyl)-4-(4-(3-(p-tolyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)piperazine-1-carbonyl)pyrrolidin-2-one结构式
|
常用名 | 1-(p-tolyl)-4-(4-(3-(p-tolyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)piperazine-1-carbonyl)pyrrolidin-2-one | 英文名 | 1-(p-tolyl)-4-(4-(3-(p-tolyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)piperazine-1-carbonyl)pyrrolidin-2-one |
|---|---|---|---|---|
| CAS号 | 920384-78-7 | 分子量 | 496.6 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C27H28N8O2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 1-(p-tolyl)-4-(4-(3-(p-tolyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)piperazine-1-carbonyl)pyrrolidin-2-one |
|---|
| 分子式 | C27H28N8O2 |
|---|---|
| 分子量 | 496.6 |
| InChIKey | TYAHHGMRIWRQLF-UHFFFAOYSA-N |
| SMILES | Cc1ccc(N2CC(C(=O)N3CCN(c4ncnc5c4nnn5-c4ccc(C)cc4)CC3)CC2=O)cc1 |
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|